Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · IEX Real-Time Price · USD
4.120
-0.120 (-2.83%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Acelyrin Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current2023
Market Capitalization
408726
Enterprise Value
-2696
PE Ratio
--1.90
PB Ratio
0.631.11
P/FCF Ratio
-3.37-4.22
P/OCF Ratio
-3.29-4.28
EV/EBITDA Ratio
0.06-0.02
EV/EBIT Ratio
0.06-0.02
EV/FCF Ratio
0.07-0.04
Debt / Equity Ratio
0.000.00
Debt / EBITDA Ratio
0.000.00
Debt / FCF Ratio
-0.01-0.01
Quick Ratio
12.988.47
Current Ratio
13.278.65
Return on Equity (ROE)
-33.90%-74.60%
Return on Assets (ROA)
-31.20%-57.00%
Return on Capital (ROIC)
-50.37%-64.19%
Earnings Yield
-58.86%-52.56%
FCF Yield
-48.23%-23.69%
Buyback Yield / Dilution
-377.81%-4410.31%
Total Shareholder Return
-377.81%-4410.31%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).